Detalles de la búsqueda
1.
Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary Report
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268247
2.
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-449914
3.
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271830
4.
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427948
5.
Fc-gamma receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-518117
6.
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474432
7.
Immune Memory Response After a Booster Injection of mRNA-1273 for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264089
8.
A Bivalent Omicron-containing Booster Vaccine Against Covid-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22276703
9.
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-439482
10.
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-479419
11.
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-511319
12.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-457693
13.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-507614
14.
Safety and Immunogenicity of an Omicron BA.4/BA.5 Bivalent Vaccine against Covid-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283166
15.
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-479468
16.
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-440647
17.
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-465542
18.
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456015
19.
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-445189
20.
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-479037
Resultados
1 -
20
de 20
1
Próxima >
>>